Molecular characterization of newborn glaucoma including a distinct aniridic phenotype

Arif O Khan1, Mohammed A Aldahmesh, Lama Al-Abdi

  • 1Pediatric Ophthalmology, King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia. arif.khan@mssm.edu

Ophthalmic Genetics
|February 11, 2011
PubMed

Insights

Newborn glaucoma in Saudi Arabia is primarily caused by CYP1B1 gene mutations, even with iris abnormalities. This study identified the common p.G61E mutation and novel CYP1B1 variants, highlighting its significance in the region.

Area of Science:

  • Ophthalmology
  • Medical Genetics

Background:

  • Buphthalmos, a form of infantile glaucoma, presents with enlarged corneas and can be associated with iris abnormalities.
  • Genetic factors are crucial in the etiology of congenital glaucoma, particularly in consanguineous populations.

Purpose of the Study:

  • To identify the genetic basis of buphthalmos in Saudi newborns, including cases with developmental iris anomalies.
  • To investigate the role of specific genes, such as CYP1B1, PAX6, FOXC1, PITX2, and LTBP2, in the pathogenesis of this condition.

Main Methods:

  • A prospective case series involving 67 Saudi Arabian newborns with buphthalmos.
  • Genetic analysis included CYP1B1 sequencing for all probands, with additional sequencing of PAX6, FOXC1, and PITX2 for selected cases.
  • LTBP2 sequencing was performed on CYP1B1-negative patients.

Main Results:

  • CYP1B1 mutations were identified in 91% of the probands, with the p.G61E mutation being the most prevalent.
  • All 8 probands with ectropion uveae and partial aniridia carried CYP1B1 mutations.
  • Four novel CYP1B1 mutations were discovered, and no mutations were found in the other screened genes.

Conclusions:

  • Newborn glaucoma in the Arabian Peninsula is predominantly linked to CYP1B1 mutations, irrespective of iris abnormalities.
  • The findings suggest that CYP1B1 mutations are a primary cause of newborn glaucoma in this population, with p.G61E being a major contributor.
  • The 9% of CYP1B1-negative cases lacking LTBP2 mutations indicate the potential existence of additional genetic loci for this condition.
Abstract

Related Concept Videos

Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Genetic Lingo01:11

Genetic Lingo

Overview
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...